Effect of sufentanil on EI90 of ropivacaine during program-controlled epidural intermittent pulse infusion after laparoscopic radical gastrectomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053447

Enrollment

Unknown

Registered

2021-11-21

Start date

2021-11-08

Completion date

Unknown

Last updated

2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic radical gastrectomy

Interventions

control group:Ropivacaine

experimental group:Ropivacaine and sufentanil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Patients with ASA grade I-III; 3. Patients with Selective laparoscopic radical gastrectomy for gastric cancer.

Exclusion criteria

Exclusion criteria: 1. Patients allergic to ropivacaine, sufentanil, and all drugs in the study; 2. Patients with contraindications to epidural anesthesia; 3. Patients with non-intentional rupture of the dural membrane; 4. Recent use of sedatives, opioids, drug addiction patients.

Design outcomes

Primary

Measure	Time frame
Pain VAS Score;	—

Secondary

Measure	Time frame
Time of first PCEA;Number of PCEA;Remedial analgesia;Postoperative analgesia satisfaction rate;First exhaust time;Time of first feeding;First time out of bed;hospital stays;Postoperative adverse reaction;	—

Countries

China

Contacts

Public ContactWang Fangjun

North Sichuan Medical College

wfjlxy006@126.com+86 13458253172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026